Prof. Dr. Petros GRIVAS
MD, PhD, Physician Seattle Cancer Care Alliance, Associate Professor, Division of Medical Oncology, University of Washington School of Medicine, Clinical Director, Genitourinary Cancers Program, UW Medicine, Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center.
I am a board-certified medical oncologist who specializes in treating patients with genitourinary cancers, such as bladder cancer and prostate cancer. My background includes leading the bladder/urothelial cancer program at the Cleveland Clinic and caring for patients at the University of Michigan, Ann Arbor. Currently, I serve as the director of UW Medicine's Genitourinary Cancers Program, giving frequent lectures, educating other oncologists and trainees and publishing novel research. I also conduct clinical trials, one of which led to the FDA approval of new drugs for bladder and urothelial cancer.
Prof. Dr. Delvys RODRIGUEZ-ABREU
MD, PhD, Head of Medical Oncology Department, Director of the Clinical Research Unit, Hospital Universitario Insular of Gran Canaria, Spain.
Prof.Dr. Delvys Rodriguez-Abreu obtained his medical degree in 1998 at the University of Havana, Cuba. He trained in internal medicine and medical oncology at the National Institute of Oncology in Havana, Cuba. After completing the specialty Board in Oncology in 2003, he joined the Medical Oncology Division at National Institute of Oncology in Havana.
To deepen his training, he spent 2 years at the Oncology Institute of Southern Switzerland, Bellinzona, Switzerland where he obtained the European Certification in Medical Oncology. Afterwards, he spent one year as Clinical and Research Fellow in lung cancer, at the Catalan Institute of Oncology in Barcelona, Spain, where he obtained the Spanish Certification in Medical Oncology.
In 2008 he joined the Medical Oncology Service at Hospital Universitario Insular of Gran Canaria, Spain, where he is now Head of Medical Oncology Department and director of the clinical research unit. He is a member of ASCO, ESMO, IASLC and the Spanish Society for Medical Oncology. He is also a member of the board of directors of Spanish Lung Cancer Group and the Spanish Group for Cancer Immuno-Biotherapy.
Dr Rodriguez-Abreu´s research interests are focused on lung cancer and melanoma. He has also been involved in the clinical development of new immunotherapy drugs, new chemotherapy agents and a variety of antiangiogenic agents. He has published several peer-reviewed articles in addition to abstracts and book chapters, including NEJM, Lancet, JCO etc.
Prof.Dr. Gabriela E. CHIOREAN
MD, Professor of Medicine, Director, GI Oncology Program, Co-Leader, Pancreas Cancer Program, Vice-Chair, National Cancer Institute- SWOG Cancer Research Network, University of Washington School of Medicine, Fred Hutchinson Cancer Center, Seattle, Washington, USA;
Dr. Gabriela Chiorean strives to improve care for patients with gastrointestinal and pancreatic cancers. She leads early-stage clinical trials of new therapies for these cancers, including new chemotherapies, immunotherapies and targeted drugs. She also aims to identify biomarkers of cancer, such as molecules in the blood, that could be developed into a minimally invasive test for the early detection of cancers or precancers.
Dr. Evangelia D. RAZIS
MD, PhD, Medical Oncologist, Director 3rd Oncology Department, Director Contemporary Oncology Team, Hygeia Hospital, Athens, Greece;
Dr.Evangelia Razis is a member of ASCO’s International Affairs Committee and Director of the 3rd Oncology Department and Contemporary Oncology Team at the Hygeia Hospital in Athens, Greece.
MD at the NORTHWESTERN University of Chicago, and PhD at the University of Crete, member of the editorial board of the Journal of Oncology Practice, she served as member of the ASCO International Affairs and QOPI steering group, Dr Razis is specialized in breast cancer, gastrointestinal and lung cancer, and special interest on Neuro-oncology and clinical research.
Dr. Razis is also a representative figure in the medical oncology community in Greece, joining ASCO's Quality Oncology Practice Initiative (QOPI) in 2013, her institution being one of the first ones to join this programme outside the United States and the first to be accredited.
Prof. Dr. Alina M. MIHAI
MD, MS, Consultant Radiation Oncologist, Clinical Associate Professor, UCD School of Medicine, Director of Oncology Research, Beacon Hospital, Dublin, Ireland
Prof. Alina Mihai is a full time Consultant Radiation Oncologist at Beacon Hospital, UCD Clinical Assistant Professor and our Director of Oncology Research. She founded the annual Irish SRS/SBRT Symposium which continues to expand and is recognized internationally. She is the Scientific Program Chair and Head of the Organising Committee. She is also part of the Scientific and Organising Committee of the Annual Best of ASCO-Best of ASTRO meeting, taking place in Romania since 2016.
Prof. Dr. M. Saiful HUQ
PhD, DABR, FAAPM, FinstP, Past President of AAPM, Professor, Director of Medical Physics Division, Department of Radiation Oncology, University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA;
Dr. Magdolna DANK
MD, Medical Oncologist, Head of Oncology, Semmelweis University of Medicine
Dr. Daniela MATEI
MD, Diana Princess of Wales Professor in Cancer Research, Department of Obstetrics and Gynecology, Co-leader Translational Research in Solid Tumors Program Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA
Dr. István PETÁK
MD, PhD, Founder and CEO/CSO at ONCOMPASS MEDICINE
Dr. Răzvan A. POPESCU
MD, Head of Medical Oncology, Tumour Center Hirslanden, Aarau, Switzerland, ASCO Quality Training Program Steering Group member.
Dr. Mircea DEDIU
MD, Head of the Oncology Department, Sanador Hospital, Bucharest, Romania
Dr. Cristian LUNGULESCU
MD, Medical Oncologist, Oncolab, Craiova, Romania;
Dr. Andrea Onisim
MD, Medical Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania
MD, Medical Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania;
Dr. Pierre THIRION
MD, Consultant Radiation Oncologist, DES Radiotherapy, DESC Medical Oncology, FFRRCSI, Beacon Hospital, Dublin, Ireland
Prof. Dr. Dwight E. HERON
MD, MBA, FACRO, FACR, FCTSI Professor of Radiation Oncology, Otolaryngology and Head and Neck Surgery, Enterprise Medical Director for Oncology Services, Bon Secours Mercy Health System, Cincinnati, Ohio, USA;
Dr. Sébastien THUREAU
MD, PhD, Radiation Oncologist, Center Henri Becquerel, Rouen, France;
(Sitting in for Prof. Dr. Pierre VERA, Manager Center H. Becquerel, Rouen, France).
Dr. Claudiu HOPÎRTEAN
MD, Radiation Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania
Dr. Dan POP
Radiation Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania;
Dr. Flavius I. COȘER
MD, Radiation Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania;
Arh. Iulia UDREA
Architect, founder of Arhitecți Udrea SRL, founding member of Project A Zece Association, Cluj-Napoca, Romania. She has about 8 years experience in architecture and interior design projects
Arh. Mara OPREA
Architect, founder of Format AD SRL, founding member of Project A Zece Association, Cluj-Napoca, Romania. She has about 7 years experience in architecture and interior design projects.